A Case of New-onset Inflammatory Bowel Disease (IBD) Following Secukinumab (SEK) Treatment of Psoriasis: A Case Report with Clinicopathological Analysis
1. Abstract We present a case of new-onset IBD in a patient following SEK treatment for psoriasis. The Patient’s IBD symptoms were successfully treated with glucocorticoids and adalimumab. The published literature contains a small number of case reports of the new onset of IBD following the treatment of SEK. This report can provide a new …